Brief: RepliCel signs two key service partnerships for final prototype manufacturing and testing of its dermal injector
Feb 28 (Reuters) - RepliCel Life Sciences Inc RP.V
* RepliCel Life Sciences Inc - RepliCel signs two key
service partnerships for final prototype manufacturing and
testing of its dermal injector
Source text for Eikon: ID:nPn44XgwPa
Further company coverage: RP.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector